Cystic fibrosis trials in Poland

In Poland 8 Also abroad 190

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
Where
Poznan, Rabka-Zdrój
Age
18 years and over
People
64 worldwide
Run by
SpliSense Ltd.
See details and how to joinNCT06429176
No phaseTaking people
Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
Where
Krakow, Lodz, Poznan
Age
18 years and over
People
468 worldwide
Run by
Physio-Assist
See details and how to joinNCT06487273
Phase 2Not yet taking people in Poland
A Study to Access Activity and Safety with SAR445399 Compared with Placebo in Participants Aged 18 to 80 Years of Age with Non-Cystic Fibrosis Bronchiectasis
Where
Bialystok, Lodz, Wroclaw
Age
18 years and over
People
41 worldwide
Run by
Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523403-29-00
Phase 1Taking people
A Two-part study to learn the amount of polymyxin E1 in the body over time formed after a single inhaled dose of colistimethate sodium (CMS) in healthy adults (Part 1) and after single inhaled and vein-infused doses of CMS in adults with non‑cystic fibrosis bronchiectasis (NCFB) (Part 2)
Where
Bialystok, Jozefow
Age
18 years and over
People
55 worldwide
Run by
Zambon S.p.A.
See details and how to join2025-524324-22-00
Phase 2Taking people
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
Where
Białystok, Bydgoszcz, Katowice, Krakow, Ostrowiec Świętokrzyski, Piaseczno, Sosnowiec, Szczecin
Age
18 years to 85 years
People
180 worldwide
Run by
CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00
Phase 2Taking people
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
Where
Lodz, Pomorskie
Age
18 years to 85 years
People
66 worldwide
Run by
Aimmune Nestlé Health Science US R&D, LLC
See details and how to joinNCT07559175
Phase 2Taking people
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
Where
Poznań, Rabka Zdrój
Age
18 years and over
People
30 worldwide
Run by
Splisense Ltd.
See details and how to join2024-511184-28-00
Phase 2Taking people
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Where
Rabka-Zdroj, Rzeszow
Age
18 years and over
People
33 worldwide
Run by
Arcturus Therapeutics, Inc.
See details and how to joinNCT06747858 · EU 2024-517663-23-01